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Abstract
Background  and  objectives:  In  this  study,  we  investigated  the  anesthetic  and  mucosal  effects
of the  rectal  application  of  dexmedetomidine  to  rats.
Methods:  Male  Wistar  albino  rats  weighing  250--300  g  were  divided  into  four  groups:  Group
S (n  =  8)  was  a  sham  group  that  served  as  a  baseline  for  the  normal  basal  values;  Group  C
(n  =  8)  consisted  of  rats  that  received  the  rectal  application  of  saline  alone;  Group  IPDex  (n  =  8)
included  rats  that  received  the  intraperitoneal  application  of  dexmedetomidine  (100  g  kg−1);
and  Group  RecDex  (n  =  8)  included  rats  that  received  the  rectal  application  of  dexmedetomidine
(100 g  kg−1).  For  the  rectal  drug  administration,  we  used  22  G  intravenous  cannulas  with  the
stylets  removed.  We  administered  the  drugs  by  advancing  the  cannula  1  cm  into  the  rectum,  and
the  rectal  administration  volume  was  1  mL  for  all  the  rats.  The  latency  and  anesthesia  time  (min)
were  measured.  Two  hours  after  rectal  administration,  75  mg  kg−1 ketamine  was  administered
for  intraperitoneal  anesthesia  in  all  the  groups,  followed  by  the  removal  of  the  rats’  rectums
to  a  distal  distance  of  3  cm  via  an  abdominoperineal  surgical  procedure.  We  histopathologically
examined and  scored  the  rectums.
Results:  Anesthesia  was  achieved  in  all  the  rats  in  the  Group  RecDex  following  the  adminis-
tration of  dexmedetomidine.  The  onset  of  anesthesia  in  the  Group  RecDex  was  signiﬁcantly
later  and  of  a  shorter  duration  than  in  the  Group  IPDEx  (p  <  0.05).  In  the  Group  RecDex,  the
administration  of  dexmedetomidine  induced  mild--moderate  losses  of  mucosal  architecture  in
the  colon  and  rectum,  2  h  after  rectal  inoculation.
Conclusion: Although  100  g  kg−1 dexmedetomidine  administered  rectally  to  rats  achieved  a
signiﬁcantly longer  duration  of  anesthesia  compared  with  the  rectal  administration  of  saline,  our
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histopathological  evaluations  showed  that  the  rectal  administration  of  100  g  kg−1 dexmedeto-
midine  led  to  mild--moderate  damage  to  the  mucosal  structure  of  the  rectum.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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Dexmedetomidina  retal  em  ratos:  avaliac¸ão  dos  efeitos  sedativos  e  sobre  a  mucosa
Resumo
Justiﬁcativa  e  objetivos:  Neste  estudo  nós  investigamos  os  efeitos  anestésicos  e  sobre  a  mucosa
da aplicac¸ão  retal  de  dexmedetomidina  a  ratos.
Métodos:  Ratos  machos  albinos  Wistar,  pesando  250-300  g,  foram  divididos  em  quatro  grupos:
Grupo S  (n  =  8)  foi  um  grupo  sham  que  serviu  de  base  para  os  valores  basais  normais;  Grupo
C  (n  =  8)  consistiu  em  ratos  que  receberam  a  aplicac¸ão  retal  apenas  de  soro  ﬁsiológico;  Grupo
IPDex  (n  =  8)  consistiu  em  ratos  que  receberam  aplicac¸ão  intraperitoneal  de  dexmedetomid-
ina (100  g  kg−1)  e  Grupo  RecDex  (n  =  8)  consistiu  em  ratos  que  receberam  a  aplicac¸ão  retal
de  dexmedetomidina  (100  g  kg−1).  Para  a  administrac¸ão  dos  fármacos  por  via  retal,  usamos
cânulas intravenosas  de  calibre  22,  com  os  estiletes  removidos.  A  administrac¸ão  consistiu  em
avanc¸ar  a  cânula  1  cm  no  reto,  e  o  volume  de  administrac¸ão  retal  foi  de  1  mL  para  todos  os  ratos.
Os  tempos  (min)  de  latência  e  de  anestesia  foram  registrados.  Duas  horas  após  a  administrac¸ão
por via  retal,  75  mg  kg−1 de  cetamina  foram  administrados  a  todos  os  grupos  para  anestesia
intraperitoneal, seguido  por  remoc¸ão  dos  retos  dos  ratos  a  uma  distância  3  cm  distal  por  meio
de  procedimento  cirúrgico  abdominoperineal.  Os  retos  foram  histopatologicamente  examinados
e  classiﬁcados.
Resultados:  A  anestesia  foi  realizada  em  todos  os  ratos  do  grupo  RecDex  após  a  administrac¸ão
de dexmedetomidina.  O  tempo  de  início  da  anestesia  no  Grupo  RecDex  foi  signiﬁcativamente
mais longo  e  com  uma  durac¸ão  mais  curta  que  no  Grupo  IPDEx  (p  <  0,05).  No  Grupo  RecDex,  a
administrac¸ão  de  dexmedetomidina  induziu  perdas  leves  a  moderadas  da  arquitetura  da  mucosa
do  cólon  e  reto  2  h  após  a  inoculac¸ão  retal.
Conclusão: Embora  a  administrac¸ão  de  100  g  kg−1 de  dexmedetomidina  por  via  retal  em  ratos
tenha resultado  em  uma  durac¸ão  signiﬁcativamente  maior  da  anestesia,  em  comparac¸ão  com
a  administrac¸ão  retal  de  soro  ﬁsiológico,  nossas  avaliac¸ões  histopatológicas  mostraram  que  a
administrac¸ão  retal  de  100  g  kg−1 de  dexmedetomidina  ocasionou  danos  leves  a  moderados  à
estrutura  da  mucosa  retal.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  
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remedication  is  the  preoperative  nasal,  oral,  rectal,  intra-
uscular or  intravenous  administration  of  sedative  drugs  to
ower the  patient’s  fear  of  surgical  intervention,  achieve
edation and  anxiolysis,  and  decrease  the  amount  of  anes-
hetics needed.1--6 In  addition  to  benzodiazepines  such  as
idazolam, which  are  commonly  used  for  this  purpose,  the
se of  alpha  2  agonists  such  as  clonidine  and  dexmedeto-
idine is  becoming  popular.3--8 For  pediatric  patients,  it  is
ssential that  premedication  agents  are  administered  non-
nvasively,  i.e.,  transmucosally,  nasally  or  orally.3--5,7,8 Rectal
dministration is  also  preferred,  particularly  for  the  pre-
edication of  young  children.2,3,9--11 Previous  studies  have
hown that,  similar  to  midazolam  and  ketamine,  clonidine
an be  administered  rectally  for  premedication.2,9--14
Dexmedetomidine  is  an  alpha  adrenergic  agonist  with
igh levels  of  speciﬁcity  and  selectivity  to  alpha  2  recep-
ors. Dexmedetomidine  can  be  used  for  sedation,  analgesia
nd anesthesia  in  intensive  care  settings,  as  well  as  for
ocal and  regional  anesthesia  applications.8,15--17 Research
o
m
has  also  shown  that  dexmedetomidine  can  be  adminis-
ered orally,  nasally,  transmucosally  or  intramuscularly  for
remedication.4,8,18--24 However,  there  are  no  published
tudies concerning  the  rectal  application  of  dexmedetomi-
ine for  premedication.
Our hypothesis  was  that  dexmedetomidine  administered
ectally to  rats  would  produce  a  sedative  effect  with  no
amage to  the  rectal  mucosa.
To  test  this  hypothesis,  we  compared  the  anesthetic
ffects of  equal  doses  of  dexmedetomidine  administered
ectally or  intraperitoneally  to  rats.  In  addition,  we  com-
ared the  histopathological  effects  on  rectal  mucosa  of
ectally administered  dexmedetomidine.
aterials and methodsf the  Bulent  Ecevit  University  (formerly  Zonguldak  Karael-
as University)  Medical  School.  All  the  animals  were  treated
umanely and  in  compliance  with  the  recommendations  of
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the  university’s  animal  care  committee  and  the  principles  of
laboratory animal  care  (NIH  publication  no.  85-23,  revised
in 1985).  The  rats  were  housed  in  a  temperature-controlled
room (24  ±  1 ◦C)  on  a  12-h  light--12-h  dark  cycle,  and  they
were fed  standard  rat  chow  and  water  until  12  h  before  the
experimental protocol.
Thirty-two  male  Wistar  albino  rats  weighing  between  250
and 300  g  were  randomly  divided  into  four  groups  of  eight
rats. Group  S  (n  =  8)  was  a  sham  group  served  as  a  base-
line for  the  normal  basal  values;  Group  C  (n  =  8)  consisted
of rats  that  received  the  rectal  application  of  saline
alone; Group  IPDex  (n  =  8)  included  rats  that  received  the
intraperitoneal application  of  dexmedetomidine;  and  Group
RecDex (n  =  8)  included  rats  that  received  the  rectal  appli-
cation of  dexmedetomidine.
The rats’  weights  were  measured  prior  to  the  exper-
iment. For  rectal  drug  administration,  we  used  22  G
intravenous cannulas  with  the  stylets  removed.  We  admin-
istered the  drugs  by  advancing  the  cannula  1  cm  into  the
rectum, and  the  rectal  administration  volume  was  1  mL  for
all the  rats.25
We  identiﬁed  the  onset  and  duration  of  anesthesia  in
all the  groups  by  observing  the  righting  reﬂex.26 We  mea-
sured the  latency  of  anesthesia  (the  time  required  to  lose
the righting  reﬂex)  and  the  anesthesia  time  (the  duration
of the  loss  of  the  righting  reﬂex)  in  minutes  (min).26 Two
hours after  rectal  study  drug’s  administration;  75  mg  kg−1
ketamine  was  used  in  all  the  groups  for  intraperitoneal  anes-
thesia, followed  by  the  removal  of  the  rats’  rectums  to
a distal  distance  of  3  cm  via  an  abdominoperineal  surgical
procedure.25 We  histopathologically  examined  and  scored
the rectums.27
Preliminary  study
Before  the  experiment,  we  evaluated  the  effectiveness
of different  doses  of  rectally  administered  dexmedetomi-
dine from  previous  studies.16,17,28 We  administered  1  g  kg−1,
10 g  kg−1,  50  g  kg−1 and  100  g  kg−1 dexmedetomidine
rectally  to  the  two  rats  in  each  group.25 In  the  preliminary
study, anesthesia  was  not  achieved  with  the  rectal  admin-
istration of  1  or  10  g  kg−1 dexmedetomidine;  however,
anesthesia was  obtained  in  one  of  the  rats  that  received
50 g  kg−1 dexmedetomidine  rectally  and  in  both  rats  that
received 100  g  kg−1 dexmedetomidine  rectally.  Therefore,
100 g  kg−1 was  chosen  as  the  dose  of  dexmedetomidine  to
be used  rectally  and  intraperitoneally.
Groups
The  rats  in  the  sham  group  (n  =  8)  did  not  receive  the  rec-
tal administration  of  any  substances.  These  rats  were  used
as controls  for  the  histopathological  examination  of  the
rectum. They  were  administered  75  mg  kg−1 i.p.  ketamine,
followed by  the  removal  of  the  rectum  to  a  distal  distance  of
3 cm  via  abdominoperineal  surgery.25 We  examined  the  rats’
rectums and  scored  them  histopathologically.27The  rats  in  the  control  group  (n  =  8)  received  1  mL  of
saline by  the  advancement  of  a  22  G  intravenous  cannula
with no  stylet  1  cm  into  the  rectum.  After  the  saline  admin-
istration, we  measured  the  anesthesia  duration  in  the  rats.26
i
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e  removed  their  rectums  to  a  distal  distance  of  3  cm  via
bdominoperineal surgery.26 We  examined  the  rectums  and
cored them  histopathologically.27
We  administered  100  g  kg−1 dexmedetomidine
ntraperitoneally  to  the  rats  in  group  IPDex  (intraperi-
oneal dexmedetomidine  group,  n  =  8).  We  established  the
roper dosage  of  dexmedetomidine  with  the  help  of  the
reliminary study  and  previous  research.16,17,28 After  the
dministration of  dexmedetomidine,  we  measured  the
nesthesia duration  in  the  rats.26
In  the  rectal  dexmedetomidine  group  (Group  RecDex,
 =  8),  saline  was  added  to  100  g  kg−1 dexmedetomidine  to
 total  volume  of  1  mL  and  was  administered  rectally  by
dvancing a  22  G  intravenous  cannula  with  no  stylet  1  cm  into
he rectum.  After  administering  the  dexmedetomidine,  we
easured the  anesthesia  duration  in  the  rats.26 The  rectums
f the  rats  were  removed  to  a  distal  distance  of  3  cm  via
bdominoperineal surgery.25 The  rectums  were  examined
istopathologically and  scored.27
istologic  assessment  of  colonic  mucosal  damage
or  the  light  microscopic  observation,  distal  colon  speci-
ens were  embedded  in  parafﬁn  blocks  after  being  ﬁxed
n a  10%  formalin  solution.  Five-micrometer  (5-m)  sections
ere obtained  and  stained  with  hematoxylin--eosin  and  Mas-
on’s trichrome  using  standard  methods.  A  histologist  graded
he colonic  pathological  changes  in  a  blinded  manner  using
he histologic  injury  scale  previously  developed  by  Leung
t al.27 Brieﬂy,  mucosal  damage  was  graded  from  0  to  4
ccording to  the  following  criteria:  grade  0,  normal  mucosa;
rade 1,  damage  to  the  surface  epithelium  only;  grade  2,
amage to  the  epithelium  of  the  upper  half  of  the  gland;
rade 3,  damage  to  the  majority  of  the  glandular  epithe-
ium that  did  not  extend  to  the  base  of  the  gland;  and  grade
, the  destruction  of  the  epithelium  of  the  entire  gland.
tatistical  analysis
e  performed  the  statistical  analysis  was  using  the  Statis-
ical Package  for  the  Social  Sciences  (SPSS)  version  16.0
or Windows  (SPSS,  Chicago,  IL).  For  the  scores  and  non-
ormally distributed  variables,  we  compared  the  groups
sing the  Mann--Whitney  U  and  Kruskal--Wallis  tests.  The
esults were  expressed  as  medians  (25th--75th  percentiles).
 p  value  <  0.05  was  considered  statistically  signiﬁcant.
esults
esults  concerning  the  duration  of  anesthesia  and  the  rectal
istopathological evaluations  were  obtained.
uration  of  anesthesia
e  achieved  anesthesia  in  all  the  rats  in  the  intraperitoneal
nd rectal  dexmedetomidine  groups  following  the  admin-
stration of  dexmedetomidine  (p  <  0.001).  In  both  of  these
roups, the  duration  of  anesthesia  was  signiﬁcantly  longer
han in  the  sham  and  control  groups  (p  <  0.001).  In  the  Group
PDex, the  onset  of  anesthesia  occurred  signiﬁcantly  more
4  V.  Hanci  et  al.
Table  1  Latency  of  anesthesia  and  anesthesia  time  values  according  to  group  (median  [25th--75th  percentiles]).
Group  S
(n =  8)
Group
C  (n  =  8)
Group RecDex  (n  =  8)  Group  IPDex  (n  =  8)  p
Latency  of  anesthesia  (min)  0  (0-0)  0  (0-0)  13.50  (11.25--15.75)a,b,c 8.5  (5--9.75)a,b 0.001
Anesthesia  time  (min) 0  (0-0) 0 (0-0)  62.50  (47.00--79.00)a,b,c 111.5  (96--115.0)a,b 0.001
Min: minute.
a p < 0.001 compared to Group S; Mann--Whitney U test.
b p < 0.001 compared to Group C; Mann--Whitney U test.
c p < 0.001 compared to Group IPDex; Mann--Whitney U test.
Figure  1  Representative  micrographs  of  rat  colon  sections  stained  with  hematoxylin--eosin  (A,  C,  E)  or  Masson’s  trichrome  (B,
D ).  Ra
m cale  
r
d
l
H
T
t
m
m
c
T
o
e
(
c
f
D
I
s
i
t,  F).  Normal  colonic  mucosa  of  Group  S  and  Group  C  rats  (A--D
oderate  loss  of  surface  and  glandular  epithelial  cells  (E,  F).  S
apidly  than  in  the  Group  RecDex  (p  <  0.001).  In  contrast,  the
uration of  anesthesia  in  the  Group  IPDex  was  signiﬁcantly
onger than  in  the  Group  RecDex  (p  <  0.001)  (Table  1).
istopathological  ﬁndings
he  histologic  features  of  the  colonic  and  rectal  walls  of
he Sham  and  Control  groups  were  determined  to  be  nor-
al (Fig.  1A--D).  In  the  Group  RecDex,  the  drug  induced
ild and  moderate  losses  of  the  mucosal  architecture  in  the
olon and  rectum,  2  h  after  rectal  inoculation  (Fig.  1E--F).
he histological  examinations  demonstrated  the  presence
f mucosal  damage  with  the  loss  of  surface  and  glandular
pithelial cells.  As  shown  in  Table  1,  the  microscopic  score
u
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Table  2  Histopathological  evaluation  scores  according  to  group  (
Group  S  (n  =  8)  Group  C
Microscopic  score  0  (0-0)  0  (0-0)  
a p < 0.001 compared to Group S; Mann--Whitney U test.
b p < 0.001 compared to Group C; Mann--Whitney U test.ts  treated  with  rectal  dexmedetomidine,  showing  the  mild  to
bar  =  20  m.
2  [2-2])  of  the  colons  from  the  Group  RecDex  was  signiﬁ-
antly higher  than  that  of  the  colon  and  rectum  segments
rom the  sham  and  control  rats  (p  <  0.001)  (Table  2).
iscussion
n  this  study,  rectal  dexmedetomidine  administration  was
hown to  have  anesthetic  activity  but  to  also  cause  signif-
cant mucosal  damage  to  rat  rectal  mucosa  compared  with
he sham  and  control  groups.Alpha  2  agonists  constitute  a  group  of  drugs  commonly
sed in  anesthesia  for  the  purposes  of  sedation,  analge-
ia and  anesthesia.11--14,18--24 Clonidine,  a  member  of  this
roup, can  also  be  used  for  premedication.11--14 Rectal
median  [25th--75th  percentiles]).
 (n  =  8)  Group  RecDex  (n  =  8)  p
2  (2-2)a,b 0.001
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premedication  administration  is  particularly  preferred  for
young children  due  to  the  ease  of  administration.2,3,9--11
Previous  studies  have  reported  that  clonidine  can  be
used effectively  rectally.11--14 Comparing  the  effectiveness
of rectally  administered  clonidine  to  that  of  midazolam,
Bergendahl et  al.11 found  that  the  use  of  the  former  as  pre-
medication resulted  in  lower  pain  scores  than  midazolam
in the  early  postoperative  stage.  The  authors  also  reported
that children  who  were  rectally  administered  ketamine  were
more  sedated  in  ﬁrst  24  postoperative  hours  than  those
who received  midazolam.11 In  a  study  comparing  the  rec-
tal administration  of  2.5  g  kg−1 clonidine  and  300  g  kg−1
midazolam  to  prevent  the  increase  in  neuropeptide  Y  caused
by tracheal  intubation  in  children,  Bergendal  et  al.13 con-
cluded that  there  was  no  signiﬁcant  difference  between
the two  groups.  A  study  that  investigated  the  pharma-
cokinetic characteristics  of  rectally  administered  clonidine
demonstrated that  its  maximum  plasma  concentration  was
0.77 ng  mL−1 and  that  the  time  required  to  reach  this
concentration was  51  min.14 The  same  study  found  that  the
half-life of  rectal  clonidine  was  12.5  h  and  the  bioavailability
was 95%.  The  authors  reported  that  the  plasma  concentra-
tion of  clonidine  reached  clinically  effective  levels  10  min
after rectal  administration.14 They  stated  that  2.5  g  kg−1
clonidine  rectally  administered  to  children  approximately
20 min  before  anesthesia  induction  could  achieve  a  clinically
effective plasma  concentration.14
Dexmedetomidine  is  a  highly  speciﬁc  and  sensitive
alpha adrenergic  agonist,  and  it  can  be  administered
orally, nasally,  transmucosally  or  intramuscularly  for
premedication.4,8,18--24
Özcengiz  et  al.20 showed  that  oral  dexmedetomidine
could prevent  post-sevolurane  agitation  in  children.  Yuen
et al.4 reported  that  1  g  kg−1 intranasal  dexmedetomidine
produced  signiﬁcantly  higher  sedation  in  children  aged  2--12
years compared  with  oral  midazolam.  The  authors  empha-
sized that  dexmedetomidine  and  midazolam  created  similar
premedication conditions  and  that  both  were  acceptable.4
In  another  study,  Yuen  et  al.29 found  that  sedation  began
an average  of  25  min  after  intranasal  dexmedetomidine  and
that the  mean  duration  of  sedation  was  85  min.  Sakurai
et al.21 reported  that  3--4  g  kg−1 dexmedetomidine  admin-
istered to  children  buccally  1  h  before  surgery  was  reliable
and effective.
In a  comparison  of  the  effects  of  2  g  kg−1 intranasal
dexmedetomidine  and  0.5  mg  kg−1 midazolam  for  preme-
dication in  pediatric  patients,  Talon  et  al.22 found  that
the two  drugs  had  similar  anesthesia  induction  and  recov-
ery characteristics.  However,  the  authors  reported  that
dexmedetomidine was  more  effective  in  inducing  sleep  and
that it  was  a  useful  alternative  to  oral  midazolam.22
Although  the  rectal  use  of  clonidine  and  the  oral,  nasal
and transmucosal  use  of  dexmedetomidine  for  premedi-
cation have  been  deﬁned,  there  is  no  literature  on  the  rectal
use of  dexmedetomidine.
In our  study,  the  rectal  administration  of  100  g  kg−1
dexmedetomidine  achieved  anesthesia  in  all  the  rats  in
that group.  The  duration  of  anesthesia  in  both  the  groups
that received  intraperitoneal  and  rectal  dexmedetomidine
was signiﬁcantly  longer  than  in  the  sham  and  control
groups. However,  the  onset  of  anesthesia  was  signiﬁcantly
later in  the  rectal  dexmedetomidine  group  than  in  the
C
T5
ntraperitoneal  dexmedetomidine  group,  and  the  duration
f anesthesia  was  signiﬁcantly  shorter  than  in  the  intraperi-
oneal group.
Rectal administration  is  an  alternative  method  of  pre-
edication, particularly  for  young  children.  The  absorption
echanisms of  rectally  administered  drugs  resemble  the
pper gastrointestinal  system.  Passive  transport  is  the  main
echanism of  rectal  drug  absorption.  The  absorption  speed
f rectally  administered  drugs  is  inﬂuenced  by  factors  such
s the  molecular  weight,  lipid  solubility  and  ionization
egree of  the  drug.  However,  the  rectal  administration  of
rugs has  been  reported  to  cause  side  effects  such  as  local
nﬂammation, rectal  mucosal  damage,  rectal  ulceration,
ectal bleeding  and  pain.30
The  rectal  administration  of  anesthetic  agents  may  also
ause rectal  mucosal  damage.25 Previous  studies  have  shown
hat rectally  administered  10%  methohexitone  causes  rectal
ucosal damage  in  rats  that  begins  within  minutes,  becomes
oticeable at  60  min,  and  continues  24  h.25
However,  there  have  been  only  a  few  studies  of  the  rec-
al mucosal  effects  of  alpha  2  agonists.31,32 Maxson  et  al.31
eported  clonidine  administration  to  rats  to  decrease  mucus
roduction in  an  intestinal  ischemia/reperfusion  model.  In
 case  study,  the  long-term  use  of  clonidine  was  reported
o cause  cicatricial  pemphigoid  in  the  anus,  vulva  mucosa
nd perianal  skin.32 In  that  case,  the  direct  immunoﬂoures-
ent examination  of  the  lesions  indicated  the  possibility  of
omplement-mediated tissue  damage  between  epidermal
asal cells  and  the  basal  membrane.32
In  our  literature  review,  we  were  not  able  to  ﬁnd  a  study
hat evaluated  the  effects  of  rectally  administered  cloni-
ine on  rectal  mucosa  cells.  We  found  in  our  study  that
ectally administered  100  g  kg−1 dexmedetomidine  caused
he moderate  loss  of  the  rectal  mucosal  surface  and  glandu-
ar epithelial  cells.  We  are  of  the  opinion  that  the  mucosal
amage caused  by  dexmedetomidine  may  have  a  mecha-
ism similar  to  that  of  clonidine.31,32 However,  we  did  not
nvestigate the  mechanisms  of  mucosal  damage  formation
n the  present  study.  These  preliminary  ﬁndings  in  rats  may
ot be  observed  in  rectal  mucosa  of  humans  due  to  the
igh dose  and  resulting  high  concentration  applied  to  the
ectal mucosa  in  this  study.  We  believe  that  future  studies
hould investigate  the  effects  of  dexmedetomidine  on  rectal
ucosa and  the  reversibility  of  the  damage.
The  dexmedetomidine  dosage  used  in  our  study  was  iden-
iﬁed as  the  most  effective  in  rectal  use  in  the  preliminary
tudy. Several  other  studies  have  demonstrated  neuropro-
ective effects  of  dexmedetomidine,  albeit  only  at  higher
oses (up  to  100  g  kg−1).33--35
In  conclusion,  although  the  rectal  administration
f dexmedetomidine  to  rats  achieved  a  signiﬁcantly
onger duration  of  anesthesia  compared  with  saline,  our
istopathological evaluation  showed  that  the  former  treat-
ent led  to  moderate  damage  in  the  mucosal  structure
f the  rectum.  Therefore,  for  the  rectally  safe  use  of
exmedetomidine as  premedication,  we  believe  that  future
tudies are  needed  to  reveal  the  effects  of  the  drug  on  rectal
ucosa.onﬂicts of interest
he  authors  declare  no  conﬂicts  of  interest.
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